2025 SPONSORS

 For five decades Alpha Laboratories has been providing quality supply and support to UK and international scientists for their diagnostic and laboratory product needs. The company remains today, as always, a family run business with the same vision and ethos: “Alpha Laboratories is passionate about finding new and sustainable ways to help science improve people’s lives by developing innovative Diagnostic and Laboratory solutions.” A long history of working with the National Bowel Screening Programmes, led to supporting progress to more advanced Faecal Immunochemical Testing (FIT) for both screening and symptomatic applications. Alongside this we have championed the use of calprotectin assays to diagnose and monitor Inflammatory Bowel Diseases (IBD), without the need for costly and invasive endoscopy. Our expertise in these areas enables us to support gastroenterology clinicians alongside laboratory scientists in providing patient centric, cost-efficient solutions that improve workflows and provide high quality results for diagnosis and disease management.

Crohn's & Colitis UK is the leading charity for Crohn’s Disease and Ulcerative Colitis, the two main forms of Inflammatory Bowel Disease. These are lifelong conditions for which there is no cure, and they affect more than 540,000 people in the UK.

Every year, 25,000 people are told that they have Crohn’s or Colitis. For some, the news comes as a shock. For others, it has taken many years to get that diagnosis. However the news comes, it is life-changing.

People affected by the conditions look to Crohn’s & Colitis UK for much-needed support and information. We are here to raise awareness, end taboos, and ensure that everyone living with Crohn’s or Colitis feels seen, heard and understood.

Our work with healthcare professionals has helped improve the diagnosis, treatment and management of Inflammatory Bowel Disease. But there is more to do, and we continue to advocate for the IBD community.

Lilly is a medicine company turning science into therapies to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are advancing new discoveries to address some of the world's most significant health challenges: redefining diabetes and obesity care; advancing the fight against Alzheimer's disease; providing options for debilitating immune system disorders; and transforming the management of difficult-to-treat cancers. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly UK or Eli Lilly and Company UK & Ireland: Overview | LinkedIn